ALHC
Alignment Healthcare, Inc.20.03
-0.08-0.4%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Reaffirms outlook, details AI plans
Q&A reinforced the scripted confidence in 2026 guidance and model durability through V28's final phase, but detailed MBR headwinds from 50% AEP growth in higher-year-1 LIS/duals/C-SNP mix and no sweep pickup. Management flagged mid-year AI deployment across 30 use cases post-workflow fixes, targeting admin savings and Care Anywhere stratification for 78% spenders. Ex-CA expansion eyes new state entry via deeper broker/provider ties, rates irrelevant. Chart review exposure tiny at 1% HCC. Punchy: Model wins flat rates. Investors track AI ramp and ex-CA scaling.
Key Stats
Market Cap
4.01BP/E (TTM)
-Basic EPS (TTM)
-0.11Dividend Yield
0%Recent Filings
8-K
Selling stockholder unloads 13M shares
10-K
FY2025 results
Alignment Healthcare grew Health Plan Membership 25% to 236,300 as of December 31, 2025 (FY2025 ended December 31, 2025), driving revenues up 46.1% y/y to $3.95B while improving MBR to 87.5% from 88.8% y/y, reflecting clinical model gains on returning members. Q4 momentum accelerated with 30% CAGR membership growth since inception, enabling first profitable year: $14.8M operating income, $110M Adjusted EBITDA (8111% y/y). Liquidity strengthened to $604M cash/investments; refinanced to $330M 4.25% convertible notes due 2029. CMS Star ratings remain 100% 4+ stars. Cybersecurity breaches could disrupt AVA platform and member data.
8-K
Crushed 2025 guidance, raises 2026
8-K
31% membership growth
Alignment Healthcare reports 275,300 health plan members as of January 1, 2026, up 31% year-over-year post-AEP. It guides year-end 2026 membership to 290,000-296,000 and expects consensus adjusted EBITDA of $145M to fall within full-year guidance. 2025 targets reaffirmed: 232,500-234,500 members, $3,931-$3,946M revenue. Momentum builds across markets.
10-Q
Q3 FY2025 results
Alignment Healthcare swung to an operating profit of $7.7M in Q3 ended September 30, 2025, up from a $19.5M loss y/y, as revenues rocketed 43.5% y/y to $993.7M on 25.9% membership growth to 229,600 and higher CMS rates, while medical expenses grew slower at 41.5% y/y for an 87.3% MBR (88.4% y/y). Cash swelled to $618.1M with $190.3M YTD operating cash flow; long-term debt sits at $322.7M (4.25% convertible notes due 2029). EPS reconciles at $0.02 diluted on 208.9M shares. Solid execution, yet CMS RADV audits loom.
IPO
Employees
Sector
Industry
AGL
agilon health, inc.
0.67+0.01
ALGN
Align Technology, Inc.
162.89+0.16
ALIT
Alight, Inc.
2.06+0.00
ASTH
Astrana Health Inc.
22.31+0.01
CLOV
Clover Health Investments, Corp
2.64+0.02
GOCO
GoHealth, Inc.
2.60-0.28
MOH
Molina Healthcare Inc
160.88-5.62
NEUE
NeueHealth, Inc.
6.75+0.00
OSCR
Oscar Health, Inc.
15.71-0.43
UNH
UnitedHealth Group Incorporated
334.20-6.90